chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia
Clinical narrative: Chills; Arm very sore; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Arm very sore) and FATIGUE (tiredness) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Meat allergy (No exposure for 15 years.  Hives and itching starting on face.), Penicillin allergy (No exposure for decades.  Facial swelling.) and Supraventricular tachycardia since 28-Apr-2005. Concomitant products included METOPROLOL SUCCINATE for Arrhythmia, DOCUSATE SODIUM (STOOL SOFTENER) for Constipation.   On 22-Jan-2021 at 9:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021 at 8:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (Arm very sore) and FATIGUE (tiredness). At the time of the report, CHILLS (Chills), MYALGIA (Arm very sore) and FATIGUE (tiredness) outcome was unknown. Not Provided          Treatment medication were not reported. Action taken with mRNA-1273 in response to the events were not applicable   This case was linked to MOD-2021-027374 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: got covid after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got covid after receiving the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got covid after receiving the vaccine). At the time of the report, COVID-19 (got covid after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth
Clinical narrative: dry mouth; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013M20A) for COVID-19 vaccination.     The patient's past medical history included Cancer of larynx extrinsic (excl vocal cord) (Vocal cords cancer).   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (dry mouth). At the time of the report, DRY MOUTH (dry mouth) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.  No treatment medication details was reported.  .   This case was linked to MOD-2021-245824 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and PRURITUS (itchy hands and feet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and PRURITUS (itchy hands and feet). At the time of the report, DIARRHOEA (diarrhea) had resolved and PRURITUS (itchy hands and feet) outcome was unknown. No treatment was reported. No concomitant medication was reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of over 101), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body aches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of over 101), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body aches). At the time of the report, PYREXIA (Fever of over 101), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-024802 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small 1 to 2 inch rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Small 1 to 2 inch rash) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Urticaria and Penicillin allergy (Reaction- Rash).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Small 1 to 2 inch rash). At the time of the report, RASH (Small 1 to 2 inch rash) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided No treatment medication information was provided   This case was linked to MOD-2021-046895 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Fatigue; 101 fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and PYREXIA (101 fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue) and PYREXIA (101 fever). At the time of the report, FATIGUE (Fatigue) and PYREXIA (101 fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (normal) 101.         No concomitant medication information was provided No treatment medication information was provided   This case was linked to MOD-2021-018495 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Swelling
Clinical narrative: Itching; itchy lump all over my body my butt, my leg, my arm everywhere my neck; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and SWELLING (itchy lump all over my body my butt, my leg, my arm everywhere my neck) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching) and SWELLING (itchy lump all over my body my butt, my leg, my arm everywhere my neck). At the time of the report, PRURITUS (Itching) and SWELLING (itchy lump all over my body my butt, my leg, my arm everywhere my neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by the reporter. No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic Reaction post vaccination) in a female patient of an unknown age who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced HYPERSENSITIVITY (Allergic Reaction post vaccination). At the time of the report, HYPERSENSITIVITY (Allergic Reaction post vaccination) outcome was unknown. The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) was unknown. Concomitant medications were not provided by the reporter. Treatment medications were not provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Reactions; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Reactions) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Reactions). At the time of the report, ADVERSE EVENT (Reactions) outcome was unknown.            Treatment information not provided. Concomitant mediations were not provided.   This case was linked to MOD-2021-025474 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Drug ineffective
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DRUG INEFFECTIVE (Vaccine doesn't work) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Transplant. Concurrent medical conditions included Immunosuppression (Immune suppression because of the transplant). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DRUG INEFFECTIVE (Vaccine doesn't work). At the time of the report, DRUG INEFFECTIVE (Vaccine doesn't work) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant products were not provided. Treatment medication were not reported. Company Comment: Very limited information regarding the events has been provided at this time. Further information is expected. Sender's Comments: Very limited information regarding the events has been provided at this time. Further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Adverse event
Clinical narrative: ADVERSE EVENT NOS; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (ADVERSE EVENT NOS) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 UNK. On an unknown date, the patient experienced ADVERSE EVENT (ADVERSE EVENT NOS). At the time of the report, ADVERSE EVENT (ADVERSE EVENT NOS) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided by reporter.  No treatment medication provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Visual impairment
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) and VISUAL IMPAIRMENT (Eyesight has started to decline) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Tinnitus) and VISUAL IMPAIRMENT (Eyesight has started to decline). At the time of the report, TINNITUS (Tinnitus) and VISUAL IMPAIRMENT (Eyesight has started to decline) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant products information were provided by the reporter. No treatment information provided by the reporter.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Nausea
Clinical narrative: lymph nodes are swollen; headaches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes are swollen), HEADACHE (headaches) and NAUSEA (nausea) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes are swollen), HEADACHE (headaches) and NAUSEA (nausea). At the time of the report, LYMPHADENOPATHY (lymph nodes are swollen) had not resolved and HEADACHE (headaches) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided by the reporter Concomitant medications were not provided. Patient race included.
Sex: F
Vaccine: COVID19
Symptoms: Bradykinesia, Pyrexia
Clinical narrative: Moving at slower pace; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BRADYKINESIA (Moving at slower pace) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BRADYKINESIA (Moving at slower pace) and PYREXIA (Fever). At the time of the report, BRADYKINESIA (Moving at slower pace) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm was sore) and PYREXIA (fever) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm was sore) and PYREXIA (fever). At the time of the report, DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm was sore) and PYREXIA (fever) had resolved. No Concomitant Medication was provided. No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Headache, SARS-CoV-2 test
Clinical narrative: Loss of Smell; Loss of Taste; Sinus Infection; Headache; Positive COVID-19 test; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID-19 test), ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032LZOA and 026L2VA) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Positive COVID-19 test). On an unknown date, the patient experienced ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, COVID-19 (Positive COVID-19 test), ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jul-2021, SARS-CoV-2 test: positive (Positive) Covid-19. On 06-Jul-2021, SARS-CoV-2 test: not known (Inconclusive) Currently waiting the results.         Concomitant medications were not reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: Loss of Smell; Loss of Taste; Sinus Infection; Headache; Positive COVID-19 test; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID-19 test), ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032LZOA and 026L2VA) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Positive COVID-19 test). On an unknown date, the patient experienced ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, COVID-19 (Positive COVID-19 test), ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jul-2021, SARS-CoV-2 test: positive (Positive) Covid-19. On 06-Jul-2021, SARS-CoV-2 test: not known (Inconclusive) Currently waiting the results.         Concomitant medications were not reported.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost Sense of Smell and Taste after the Second Shot) and AGEUSIA (Lost Sense of Taste after the Second Shot) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 041B21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced ANOSMIA (Lost Sense of Smell and Taste after the Second Shot) and AGEUSIA (Lost Sense of Taste after the Second Shot). At the time of the report, ANOSMIA (Lost Sense of Smell and Taste after the Second Shot) and AGEUSIA (Lost Sense of Taste after the Second Shot) was resolving. No concomitant medications was reported. No treatment information was not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pruritus, Rash macular
Clinical narrative: Red blotches on her arms, face, back, thigh and chest areas; Itchy red blotches; Cannot sleep; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MACULAR (Red blotches on her arms, face, back, thigh and chest areas), PRURITUS (Itchy red blotches) and INSOMNIA (Cannot sleep) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome, Polymyalgia rheumatica, Sjogren's syndrome, Raynaud's syndrome and Hyperthyroidism.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced RASH MACULAR (Red blotches on her arms, face, back, thigh and chest areas), PRURITUS (Itchy red blotches) and INSOMNIA (Cannot sleep). At the time of the report, RASH MACULAR (Red blotches on her arms, face, back, thigh and chest areas), PRURITUS (Itchy red blotches) and INSOMNIA (Cannot sleep) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were not reported.  Treatment included an unspecified cream.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pain, Pyrexia, Rash
Clinical narrative: Body ache; skin rash around my neck and underneath my arm pits and was treated for one month; Fever; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body ache), RASH (skin rash around my neck and underneath my arm pits and was treated for one month), PYREXIA (Fever) and HEADACHE (headache) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) from 06-Jan-2019 to an unknown date and LISINOPRIL from 06-Jan-2019 to an unknown date for an unknown indication.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (Body ache), RASH (skin rash around my neck and underneath my arm pits and was treated for one month), PYREXIA (Fever) and HEADACHE (headache). On 16-Feb-2021, PAIN (Body ache), PYREXIA (Fever) and HEADACHE (headache) had resolved. On 17-Mar-2021, RASH (skin rash around my neck and underneath my arm pits and was treated for one month) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 101 (High) The patient body temperature was 101..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient went to dermatologist for rash and treated with steroid cream from 17 Feb 2021 to 17 Mar 2021. And rash was remained for 1 month.  No further treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given expired vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications was not mentioned
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.            Concomitant medication was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). On 05-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.            No relevant concomitant medications were provided.  Treatment information was not provided.  It was reported that they received vaccine on 28-May-2021 and the vaccine use date was 27-Jun-2021 once it was refrigerated.
Sex: M
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (has no hair, is completely bald with no hair in the head) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No specified medical history has been reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (has no hair, is completely bald with no hair in the head). At the time of the report, ALOPECIA (has no hair, is completely bald with no hair in the head) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information not provided. Concomitant medications were not provided. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up information received on 06-Jul-2021 contains no significant information.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema
Clinical narrative: significant bruising patterns with red dots on her right arm near her vaccination site; red dots on her right arm near her vaccination site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE BRUISING (significant bruising patterns with red dots on her right arm near her vaccination site) and VACCINATION SITE ERYTHEMA (red dots on her right arm near her vaccination site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (significant bruising patterns with red dots on her right arm near her vaccination site) and VACCINATION SITE ERYTHEMA (red dots on her right arm near her vaccination site). At the time of the report, VACCINATION SITE BRUISING (significant bruising patterns with red dots on her right arm near her vaccination site) and VACCINATION SITE ERYTHEMA (red dots on her right arm near her vaccination site) outcome was unknown.            Concomitant product use was not provided by the reporter.   Treatment information was not provided.  Patient reported she is a veterinarian so explained she understands the medical world and she has followed up with rheumatologist and dermatologist and neither of her doctors can explain hey symptoms.   Patient reported two weeks after her second dose she had significant bruising patterns with red dots on her right arm near her injection site.  She explained that they were not raised or elevated or itchy. Patient reported this went away, then two weeks later came back but was not as intense. Patient reported her symptoms then went away and two weeks later returned again. Patient reported she has an autoimmune disorder.  Patient explained that since being vaccinated, anytime she has a bump or runs into something or cuts herself on a thorn, a similar looking bruise pattern/red dot appeared.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chest X-ray, Chest discomfort, Chills
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 from 13-Jan-2021 to 30-Jan-2021. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), ILLNESS (Sickness), COUGH (chest pressure cough), FATIGUE (exhausted), VOMITING (vomiting), HEADACHE (Headaches), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with ALBUTEROL [SALBUTAMOL] from 10-Feb-2021 to 20-Feb-2021 for COVID-19, at a dose of 1 dosage form four times per day. At the time of the report, DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), ILLNESS (Sickness), COUGH (chest pressure cough), PYREXIA (Fever), FATIGUE (exhausted), VOMITING (vomiting), HEADACHE (Headaches), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Chest X-ray: (normal) no infiltrate or pleural effusion, no acute disease. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication were reported. This case was linked to MOD-2021-024986 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Fatigue, Headache
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 from 13-Jan-2021 to 30-Jan-2021. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), ILLNESS (Sickness), COUGH (chest pressure cough), FATIGUE (exhausted), VOMITING (vomiting), HEADACHE (Headaches), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with ALBUTEROL [SALBUTAMOL] from 10-Feb-2021 to 20-Feb-2021 for COVID-19, at a dose of 1 dosage form four times per day. At the time of the report, DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), ILLNESS (Sickness), COUGH (chest pressure cough), PYREXIA (Fever), FATIGUE (exhausted), VOMITING (vomiting), HEADACHE (Headaches), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Chest X-ray: (normal) no infiltrate or pleural effusion, no acute disease. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication were reported. This case was linked to MOD-2021-024986 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 from 13-Jan-2021 to 30-Jan-2021. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), ILLNESS (Sickness), COUGH (chest pressure cough), FATIGUE (exhausted), VOMITING (vomiting), HEADACHE (Headaches), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with ALBUTEROL [SALBUTAMOL] from 10-Feb-2021 to 20-Feb-2021 for COVID-19, at a dose of 1 dosage form four times per day. At the time of the report, DIARRHOEA (Diarrhea), CHEST DISCOMFORT (chest pressure), DYSPNOEA (Difficulty in breathing), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), ILLNESS (Sickness), COUGH (chest pressure cough), PYREXIA (Fever), FATIGUE (exhausted), VOMITING (vomiting), HEADACHE (Headaches), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Chest X-ray: (normal) no infiltrate or pleural effusion, no acute disease. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication were reported. This case was linked to MOD-2021-024986 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) outcome was unknown.            Treatment information not provided. concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling in armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Infertility. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swelling in armpit). At the time of the report, LYMPHADENOPATHY (swelling in armpit) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Antibiotics are taken as concomitant medication. No treatment drugs were reported. This case was linked to MOD-2021-194126 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash all over their body; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over their body) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash all over their body). At the time of the report, RASH (rash all over their body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. Concomitant medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: dose was given from a vial that had had been punctured for 12 plus hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given from a vial that had had been punctured for 12 plus hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given from a vial that had had been punctured for 12 plus hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given from a vial that had had been punctured for 12 plus hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy to vaccine, Discomfort, Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic reaction in both arms), DISCOMFORT (Uncomfortable) and PRURITUS (Itches) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009D21A and 041B21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jul-2021, the patient experienced ALLERGY TO VACCINE (Allergic reaction in both arms), DISCOMFORT (Uncomfortable) and PRURITUS (Itches). At the time of the report, ALLERGY TO VACCINE (Allergic reaction in both arms), DISCOMFORT (Uncomfortable) and PRURITUS (Itches) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment with antihistamine pills and cream for itchiness taken to alleviate the symptoms experienced.
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate decreased
Clinical narrative: heart rate got down to 30; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE DECREASED (heart rate got down to 30) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE DECREASED (heart rate got down to 30). The patient was treated with Surgery (Cardiac pace-maker insertion) for Heart rate decreased. At the time of the report, HEART RATE DECREASED (heart rate got down to 30) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 30 abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pain
Clinical narrative: Flu like symptoms; Sore injection site left arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Sore injection site left arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Sore injection site left arm). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Sore injection site left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-248055 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash all over body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash all over body) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rash all over body). The patient was treated with HYDROXYZINE HYDROCHLORIDE (VISTARIL [HYDROXYZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; FAMOTIDINE (PEPCID AC) for Adverse event, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (Rash all over body) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Patient went to the hospital on 01 Jul 2021 and 05 Jul 2021.  The lab test included some unspecified blood tests, whose results are not reported. Treatment also included Steroids.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 2nd dose administered out a vail that was thawed more than 30 days.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd dose administered out a vail that was thawed more than 30 days.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd dose administered out a vail that was thawed more than 30 days.). On 01-Jul-2021, EXPIRED PRODUCT ADMINISTERED (2nd dose administered out a vail that was thawed more than 30 days.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was reported.